Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis

Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis

Ginseng, the root and rhizome of Panax ginseng C. A. Mey., is a famous herbal medicine, and its major ginsenosides exert beneficial effects on nonalcoholic fatty liver disease (NAFLD). Due to the multicomponent and multitarget features of ginsenosides, their detailed mechanisms remain unclear. This...

Full description

Bibliographic Details
Main Authors: Wenyi Liang, Kun Zhou, Ping Jian, Zihao Chang, Qiunan Zhang, Yuqi Liu, Shuiming Xiao, Lanzhen Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Pharmacology
Subjects:
ginsenosides
nonalcoholic fatty liver disease
network pharmacology
gut microbiota
inflammation
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.622841/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.622841/full

Similar Items